Italia markets closed

The Cooper Companies, Inc. (COO)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
410,07+5,99 (+1,48%)
Alla chiusura: 4:03PM EDT

The Cooper Companies, Inc.

6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
United States
925 460 3600
http://www.coopercos.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno12.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Albert G. White IIIPres, CEO & Non-Independent Director1,81MN/D1970
Mr. Brian G. AndrewsExec. VP, CFO & Treasurer762,01kN/D1979
Mr. Daniel G. McBrideExec. VP & COO1,14MN/D1964
Ms. Holly R. SheffieldPres of CooperSurgical, Inc.815,4kN/D1971
Mr. Agostino RicupatiSr. VP of Fin. & Tax and Chief Accounting OfficerN/DN/D1967
Mr. Kim DuncanVP of Investor Relations & Risk ManagementN/DN/DN/D
Mr. Mark J. DruryVP, Gen. Counsel & Corp. Sec.N/DN/D1976
Mr. Juan Carlos AragónPres of CooperVision Specialty EyeCare DivisionN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.

Governance aziendale

L'ISS Governance QualityScore di The Cooper Companies, Inc. al 1 luglio 2021 è 4. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 4; diritti degli azionisti: 2; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.